Navigation Links
Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
Date:10/21/2007

Japan, Plavix(R) is the only widely approved antiplatelet agent used in monotherapy for prevention of atherothrombotic events in patients with recent myocardial infarction (hear attack), recent ischaemic stroke or established peripheral arterial disease, and in combination with acetylsalicylic acid for the treatment of patients with acute coronary syndrome (unstable angina or NSTEMI) including those who are to be managed medically and those managed with PCI (with or without stent) and for STEMI patients.

Plavix(R) is one of the most studied cardiovascular medications available to patients with short and long term clinical benefit, and after a decade of prescriptions, it remains the oral antiplatelet therapy with the broadest range of indications worldwide.

About Plavix(R)

Plavix(R), also marketed as Iscover(R), is an antiplatelet agent which prevents platelets from sticking together and forming clots in the arteries. Plavix(R) was first authorized in the United States in 1997 and the European Union in 1998 and has been prescribed to more than 70 millions patients worldwide.

In Japan, in addition to the new approval for acute coronary syndrome (unstable angina pectoris, non-ST elevation myocardial infarction) for which percutaneous coronary intervention (PCI) is planned, Plavix(R) is also approved for "reduction of recurrence after ischemic cerebrovascular disorder (excluding cardiogenic cerebral embolism)" one of the 3 major causes of death in Japan.

The efficacy and safety profile of Plavix(R) have been established through landmark clinical trials including more than 100,000 patients worldwide. Outside Japan, Plavix(R) has shown favourable tolerability profile as compared to ASA and an acceptable increase in major bleedings when used in combination with ASA (no statistical difference when only PCIs are considered).

In Japan, Plavix(R) is marketed by sanofi-aventis K.K. Plavix(R) is marketed in more than 100 countries by sanofi-a
'/>"/>

SOURCE sanofi-aventis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action
2. Vical Licensee AnGes MG Announces Positive Results of Phase 3 Angiogenesis Trial in Japan
3. First Controlled Large-Scale Intervention Angiotensin Receptor Blocker (ARB) Trial in a Japanese Population, JIKEI HEART Study Demonstrates Significant Reduction in Blood Pressure and Protection of Organs with Valsartan
4. LANI completes Phase I in Japan and to commence Phase I in UK
5. AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a Trial
6. New Data from the US and Japan Support: No Established Causal Link Between Neuropsychiatric Symptoms and Treatment with Tamiflu US Databases Indicate Psychiatric Symptoms Lower in Influenza Patients Taking Tamiflu Versus Those Not Taking Tamiflu
7. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
11. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... YORK , Sept. 2, 2014 Reportlinker.com ... in its catalogue: Asia - Pacific ... http://www.reportlinker.com/p02353212/Asia---Pacific-Minimally-Invasive-Surgery-Spinal-Device-Market.html The growth rate of ... spinal device market will remain at double-digit levels throughout ... surgeries as the future of this field. The ...
(Date:9/2/2014)... -- Perrigo Company plc, a public limited company incorporated under ... Company "), today announced that it is offering to exchange ... Senior Notes due 2016 (the " 2016 Exchange Notes "), ... " 2018 Exchange Notes "), $800,000,000 of its new 4.00% ... and $400,00,000 of its new 5.30% Senior Notes due 2043 ...
(Date:9/2/2014)... , Sept. 2, 2014  Ameritox SM , ... "A Deadly Trend: Prescription Drugs to Heroin," a research ... to heroin abuse, and examines deadly trends that have ... found here . The report ... of patients prescribed opioids. It examines five trends that ...
Breaking Medicine Technology:Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 2Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 3Perrigo Company plc Announces Exchange Offer For Its 1.30% Senior Notes Due 2016, 2.30% Senior Notes Due 2018, 4.00% Senior Notes Due 2023 and 5.30% Senior Notes Due 2043 4Ameritox Research Report Reveals Pain Patients' Role in Current Heroin Epidemic 2
... Inc., a pharmaceutical company advancing orally-available antiviral therapeutics to ... President and Chief Executive Officer, will present at the ... 2011 at 3:00 p.m. ET at the Hilton New ... Mr. Moch will give an update on the company,s ...
... Codexis, Inc. (Nasdaq: CDXS ) today announced ... Officer and Senior Vice President, Process Development and Manufacturing, a ... Ph.D., President and Chief Executive Officer. Dr. ... DuPont. He served as Vice President, Research and Development for ...
Cached Medicine Technology:Chimerix to Present at the Citi 2011 Global Health Care Conference 2Chimerix to Present at the Citi 2011 Global Health Care Conference 3Codexis Names David Anton CTO & SVP, Process Development & Manufacturing 2
(Date:9/2/2014)... On August 30, 2014, Harper’s Bazaar ... You Should Wash Your Face .” According to ... population breathes air considered polluted by the World Health ... the skin’s pores destroying its natural oils. These oils ... that may cause cell damage, redness, aging skin ...
(Date:9/2/2014)... patients treated with lumpectomy followed by radiation therapy ... mastectomy, according to a large study conducted by ... and the Cancer Prevention Institute of California. , ... with the disease is the first to directly ... surgical interventions: bilateral mastectomy (the removal of both ...
(Date:9/2/2014)... 2, 2014 In a large population-based study ... that mild cognitive impairment (MCI) occurred twice more ... 2. Interestingly, this strong association was only observed ... participants (66-80 years) the association vanished. This study ... Disease . , The concept of MCI describes ...
(Date:9/2/2014)... within a few days of discharge do so principally because ... in other parts of the health care system, according to ... Annals of Emergency Medicine ( "Return Visits to the ... asked why they did not follow up as an outpatient, ... wait until their scheduled appointment or being instructed to return ...
(Date:9/2/2014)... 02, 2014 The Dream2Walk Foundation along with ... Sept. 14th, 2014 during Spinal Cord Injury Awareness Month featuring ... England, and Chuck Ligon. Linear Automotive will be there hosting ... , Doors open at 2pm. The car show is Pre ... free pass to the concert. There will be trophies for ...
Breaking Medicine News(10 mins):Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 2Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 3Health News:Breast cancer patients with bilateral mastectomy don't have better survival rates 4Health News:Diabetes mellitus and mild cognitive impairment: Higher risk in middle age? 2Health News:Discharged patients return to the ER because 'better safe than sorry' 2Health News:Gas Monkey Hosts Concert in Dallas Benefiting Dream2Walk Foundation with Linear Automotive 2
... Is it safe to wait to make a,decision about ... for all the doctor appointments and test results? Or ... Reassuring research,says that men can take the time they ... of Harvard Men,s Health Watch., One study evaluated ...
... and caregivers offers tips to families, friends, caregivers ... ... CHICAGO, Feb. 4 What do you say, what can you ... from a serious,disease? To kick-off National Patient Recognition Week, a week-long,observance ...
... More than half a million women around the world, ... natural family planning methods developed by Georgetown University Medical ... and thousands of others use CycleBeads a visual aid ... fertility to plan or prevent pregnancy. , Now ...
... York Methodist Hospital today announced the start of the ... multi-center clinical trial to explore an investigational treatment that ... suffering with advanced widespread emphysema. The study focuses on ... in the lung for trapped air to escape and ...
... the Stowers Institutes Trainor Lab has demonstrated that it can ... a gene implicated in the abnormality or by inhibiting its ... the Web site of the journal Nature Medicine yesterday, is ... cause of TCS. , The team evaluated how a ...
... Provide Insight ... 50+-year Relationships, MCLEAN, Va., Feb. 4 Sunrise Senior Living,(NYSE: ... services with,more than 450 communities worldwide, shared the results of a ... spent more than,five decades of special Valentine,s Days together., Sunrise ...
Cached Medicine News:Health News:Men Can Take Their Time to Decide on Prostate Cancer Treatment, Reports the Harvard Men's Health Watch 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 2Health News:It's National Patient Recognition Week - Here's How You Can Do Something Special for Someone Facing Illness 3Health News:CycleBeads help women manage their fertility 2Health News:New York Methodist Hospital to study airway bypass treatment for emphysema 2Health News:Trainor Lab prevents rare birth defect by inactivating p53 gene 2Health News:Secrets to Long-Lasting Marriages Revealed in Senior Survey 2Health News:Secrets to Long-Lasting Marriages Revealed in Senior Survey 3
... 3 year warranty Set one of ... for B.I.O. exam!, One touch auto return ... in 4 colors , Solid-State push button ... holder and transformer. , Electro-Magnetic counter-balanced slit ...
3.5v Standard Ophthalmoscope Set with Convertible Handle and Soft Case. Our Standard Ophthalmoscope Sets feature high-quality instruments, handles, and cases....
High-quality eyecare from the preferred name in diagnostic instruments....
Our 3.5v Streak or Spot Retinoscope Sets feature instruments with the brightest light output in the industry, reliable handles, and convenient cases....
Medicine Products: